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Abstract
Background: Guolin Qigong is a combination of meditation, controlled breathing and physical
movement designed to control the vital energy (qi) of the body and consequently to improve
spiritual, physical and mental health. Practice of Qigong has been reported to alter immunological
function, but there have been few studies of its effects on cytokines, the key regulators of immunity.
Methods: Numbers of peripheral blood cytokine-secreting cells were determined by ELISPOT in
19 healthy volunteers aged 27 – 55, before they were taught the practice of Qigong and after 3, 7
and 14 weeks of daily practice. The effect of Qigong on blood cortisol was also examined.
Results: Numbers of IL4 and IL12-secreting cells remained stable. IL6 increased at 7 weeks and
TNFα  increased in unstimulated cultures at 3 and 7 weeks but decreased at these times in LPS and
SAC-stimulated cultures. Of particular interest, IFNγ -secreting cells increased and IL10-secreting
cells decreased in PHA-stimulated cultures, resulting in significant increases in the IFNγ :IL10 ratio.
Cortisol, a known inhibitor of type 1 cytokine production, was reduced by practicing Qigong.
Conclusion: These preliminary studies in healthy subjects, although not necessarily representative
of a randomized healthy population and not including a separate control group, have indicated that
blood levels of the stress-related hormone cortisol may be lowered by short-term practice of
Qigong and that there are concomitant changes in numbers of cytokine-secreting cells. Further
studies of the effect of Qigong in patients with clinical diseases known to be associated with type
2 cytokine predominance are merited.
Background
Qigong is a combination of meditation, physical move-
ments and controlled breathing. These exercises are de-
signed to develop the skill of controlling qi, the vital
energy of the body, and consequently to improve spiritu-
al, physical and mental health. Adepts can reportedly use
emitted qi to alter the performance of cells: "facilitating
qi" increases cell growth while "inhibiting qi" suppresses
growth of cultured tumour cells [1].
Guolin Qigong was introduced more than 50 years ago by
Madam Guo, a long-term cancer survivor who developed
a network of self-help groups throughout China and be-
yond. This form of Qigong, which is characterized by a
slow walking exercise accompanied by arm movements
coordinated with slight twisting movements of the waist,
is said to be particularly helpful for cancer patients.
Among the organs apparently affected by qigong are
brain, heart, kidney and the immune system, with bene-
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fits being reported in senility, hypertension, stroke, asth-
ma, blood chemistry and cancer [2–6]. (See also  [http:/
/www.goldenflower.org/reflib/articles/
tc_as_treatment.shtml] ).
The reported benefits of Qigong could be mediated by ef-
fects on immunological function and various aspects of
immune function could perhaps be influenced by qi en-
ergy. However, there have been only a few peer-reviewed
publications describing alterations in immune system
activity as a result of practicing Qigong. Delayed cutane-
ous hypersensitivity responses were faster, stronger and
more numerous in a Qigong trained group than a normal
healthy group [7]. Patients with aplastic anaemia treated
with Qigong showed significant improvement in
CD4+:CD8+ T-cell ratio [8], which also increased in new-
ly recruited Qigong trainees after 5 months of practice
[9]. CD4:CD8 T-cell ratios and NK-cell activity tended to
increase during a single 40-minute session of Qigong
[10]. Various non-reviewed studies have described in-
creased lymphocyte, neutrophil and natural killer (NK)
cell functions in subjects practicing Qigong [see Exten-
sion of Life: Documentation on the Effects of Chi Kong
Qigong (Edited by Zhang RM) Renming Tin Yue Press,
China 1995; and  [http://www.goldenflower.org/reflib/
articles/tc_as_treatment.shtml]] 
Cytokines are highly labile effector glycoproteins which
are crucially involved in afferent and efferent limbs of
immune responses as pro-inflammatory and anti-in-
flammatory regulators. Type 1 cytokines, such as inter-
feron-gamma (IFNγ ), tumour necrosis factor alpha
(TNFα ) and interleukin (IL) 12, promote cell-mediated
responses, while type 2 cytokines, including IL4, IL6 and
IL10, are anti-inflammatory and favour humoral re-
sponses [11,12]. Cell-mediated responses are important
in protection against cancers, while overproduction of
anti-inflammatory cytokines is potentially suppressive
for anti-cancer immunity. The present pilot study was
designed to investigate effects of Qigong on in vitro cy-
tokine production in healthy volunteers and to deter-
mine whether further evaluation of its effects on the
cytokine profiles of patients with cancer would be valua-
ble. We measured production of the above 6 cytokines
before Qigong training and for up to 14 weeks of per-
forming the exercises. Significant increases in PHA-
stimulated IFNγ :IL10 ratios were found, indicating a
shift towards cytokines favoring cell-mediated immuni-
ty.
Methods
Subjects and evaluations
Nineteen healthy Chinese subjects aged 27 – 55 years
(mean 43.9 ± 7.8), of whom 11 were females, were re-
cruited by advertisement for first-time training in Guolin
Qigong. One further volunteer was excluded on the
grounds of ill-health. Each subject attended six 2-hour
Qigong class in a two week period. They then practiced
the exercises every day and kept diaries to record details.
Ten subjects were still practicing Qigong at the end of the
study period (14 weeks from starting training), while 9
ceased practice at 10 weeks. Blood pressure, pulse rate,
blood cortisol level and production of IFNγ , IL4, IL6,
IL10, IL12 and TNFα  were measured before training and
after 3, 7 and 14 weeks. One subject was excluded from
the main study because of respiratory infection at 3
weeks, but was included in the 14 week comparison of
subjects who completed the study with those who
stopped, as the infection had cleared at that time.
ELISPOT assay
Numbers of cytokine-secreting cells (CK-SC) in unstim-
ulated cultures or cultures stimulated with T-cell activa-
tors phytohaemagglutinin (PHA), Concanavalin A (Con
A) or solid-phase anti-CD3, or monocyte activators E.
coli lipopolyssacharide (LPS) or S. aureus Cowan I
(SAC) were determined using ELISPOT assays [13,14].
Details of our adaptation of this method and its specifici-
ty and reproducibility have been reported [15–17]. Brief-
ly, heparinized blood was processed for cytokine
evaluations within one hour of collection. Peripheral
blood mononuclear cells (PBM) were separated over
Lymphoprep (Nycomed, Oslo, Norway) and added to 96-
well Multiscreen plates (Millipore, Bedford, MA, USA)
which had previously been coated with cytokine capture
antibodies (Pharmingen, San Diego, CA, USA) and
blocked with 5% fetal calf serum (FCS) in medium RPMI
1640. Duplicate cultures of 104 (for IL6 and TNFα ) or 105
(for IFNγ , IL4, IL10 and IL12) cells/well in RPMI + 5%
FCS with or without stimulators were incubated for 18–
22 hours at 37°C in 5% CO2. Cells were then washed out
and plates incubated sequentially with biotinylated de-
tection anti-cytokine antibodies (Pharmingen), strepta-
vidin-alkaline phosphatase (Sigma, St. Louis, MO, USA)
and 5-bromo-4-chloro-3-indolylphosphate-nitroblue
tetrazolium (Calbiochem, La Jolla, CA, USA). Blue spots
corresponding to each cytokine-SC were counted by mi-
croscopy with the aid of eyepiece graticules covering 1/8
or 1/72 of the culture well area. Results are expressed as
CK-SC/106 PBM.
Statistical analysis
Prism version 2.0 software (GraphPad, San Diego, CA,
USA) was used to compare various parameters before
and at 3, 7 and 14 weeks after starting training (paired t-
test) and to compare results at 14 weeks for subjects who
stopped performing Qigong at 10 weeks with those of
subjects who continued beyond 14 weeks (unpaired t-
test).BMC Complementary and Alternative Medicine 2001, 1:8 http://www.biomedcentral.com/1472-6882/1/8
Results
No significant changes in systolic or diastolic blood pres-
sure occurred over the study period, but pulse rate de-
creased from 76.3 ± 11.4 (mean ± SD) before training to
69.8 ± 9.4 at 3 weeks (p<0.05). However, values at 7 and
14 weeks (71.4 ± 9.5 and 74.3 ± 13.3 respectively) were
not significantly different from baseline. Plasma cortisol
levels at baseline were 394 ± 115 nmol/l and at 3, 7 and
14 weeks were 328 ± 126 (p < 0.05), 376 ± 109 (not sig-
nificant) and 318 ± 110 (p < 0.05) respectively.
Numbers of PHA, anti-CD3 and Con A-stimulated IL4-
SC (Fig. 1A) and unstimulated and PHA, anti-CD3 and
SAC stimulated IL12-SC (Fig. 1B) remained stable before
and after Qigong training. No IL4 (nor IFNγ )-SC were
seen in unstimulated cultures, as observed previously
[15–17].
IL6-SC were significantly increased after 7 weeks of exer-
cising in unstimulated, PHA-stimulated and LPS-, but
not SAC-, stimulated cultures and returned to baseline
levels at week 14 (Fig. 2A). TNFα -SC were significantly
increased at 3 and 7 weeks in unstimulated cultures and
returned to near baseline at 14 weeks. There was no sig-
nificant increase in TNFα -SC stimulated by T-cell or
monocyte activators and in fact LPS and SAC-stimulated
TNFα -SC were significantly reduced at 14 weeks com-
pared to pretraining (Fig. 2B).
Reduction in IL6 and TNFα -SC between week 7 and
week 14 could have been because approximately half of
the subjects stopped exercising at 10 weeks. This was not
so for IL6, since cytokine production was similar in those
who continued and those who stopped performing
Qigong (Fig. 3A). In contrast, stopping Qigong was asso-
ciated with a significantly lower level of unstimulated
and PHA-stimulated TNFα -SC than in those who contin-
ued (Fig. 3B).
IFNγ -SC were significantly increased in PHA-stimulated
cultures at 3, 7 and 14 weeks. The more powerful IFNγ  in-
ducers Con A and anti-CD3 stimulated levels of cytokine
production that were less influenced by practicing
Qigong, only Con A-induced IFNγ -SC at 3 weeks being
significantly higher than before training (Fig. 4A). IL10
production in unstimulated cultures increased signifi-
cantly after 7 weeks of exercises but fell back to pretrain-
ing levels at 14 weeks. PHA, LPS and SAC-induced IL10-
SC were similar to pretraining levels at weeks 3 and 7 and
lower at week 14, with PHA-induced IL10-SC being sig-
nificantly lower than before training (Fig. 4B). The ratio
of IFNγ :IL10-SC in PHA-stimulated cultures was signifi-
cantly higher at 3, 7 and 14 weeks than before training
(Fig. 4C).
IFNγ -SC, IL10-SC and the ratio of PHA-stimulated IF-
Nγ :IL10-SC at 14 weeks were not significantly different
in subjects who stopped performing Qigong exercises at
10 weeks compared with those who continued beyond 14
weeks (Fig. 5).
Discussion
Qigong has been practiced for over 3,000 years in China
and evidence of its beneficial effects in maintaining and
improving health has been presented, though largely in
journals inaccessible to the West. Wider application of
Qigong could possibly contribute to a healthier popula-
tion less dependent on modem medicines, the cost of
Figure 1
Numbers of IL4 (A) and IL12 (B) cytokine-secreting cells
(CK-SC) per 106 peripheral blood mononuclear cells (PBM)
measured by ELISPOT assay in 19 healthy volunteers before
starting Qigong training (P) and after 3, 7 and 14 weeks of
practice. There were no significant changes during the study
period.
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which is spiraling. If it were possible to identify the pre-
cise mechanisms by which Qigong achieves these sup-
posed benefits, more focused application of the exercises
and of qi energy could possibly result in generally accept-
able therapies to supplement current practices.
The present study attempted to determine whether the
key regulator molecules of the immune system, cy-
tokines, are influenced by Qigong. I chose to evaluate cy-
tokine production using ELISPOT assays because these
measure actual secreted cytokine rather than intracyto-
plasmic protein (as measured by flow cytometry) or mes-
sage (by reverse transcriptase polymerase chain
reaction) and the problem of cytokine neutralization by
concomitantly secreted antagonists or soluble receptors,
which affects measurement of cytokines in culture super-
natants, is avoided.
The ELISPOT assays established in our laboratory are
sensitive, specific (no ELISPOTs develop when un-
matched pairs of anti-cytokine antibodies are used for
capture and detection) and reproducible, with intra-as-
say coefficients of variation (CV) of 8.8 ± 5.8% for com-
bined data for IFNγ , TNFα , IL4, IL6, IL10 and IL12 and
all stimuli [15]. Inter-assay variation is 13.2 ± 4.9%, re-
flecting considerable individual day-to-day variation,
Figure 2
Numbers of IL6-SC/106 PBM were increased after 7 weeks
of Qigong practice compared with pretraining (A). Numbers
of unstimulated TNFα -SC/106 PBM were increased at 3 and
7 weeks, but LPS and SAC-stimulated TNFα -SC/106 PBM
were decreased at 14 weeks compared to pretraining (B). (1)
p < 0.01, (2) p < 0.05 compared with P, paired t-test.
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Figure 3
Numbers of IL6-SC/106 PBM (A) and TNFα -SC/106 PBM (B)
at 14 weeks in subjects who continued (C) Qigong practice
beyond 14 weeks and those who stopped (S) at 10 weeks.
(1) p < 0.05, unpaired t-test.
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but when groups of subjects are evaluated at different
time points, mean values vary by only 5.3 ± 3.8% [15].
This is acceptable for studying effects of interventions in
groups of subjects.
All recruited volunteers were normotensive before train-
ing and practicing Guolin Qigong for at least 10 weeks
did not alter blood pressure greatly. Pulse rates were
lower than baseline at 3 weeks but not at 7 or 14 weeks.
Interestingly, reduction in cortisol levels was biphasic,
with a return to pretraining levels at 7 weeks despite sig-
nificant reductions at 3 and 14 weeks. There were no sig-
nificant differences between cortisol levels in those who
stopped exercising at 10 weeks and those who continued.
It is possible that practicing Qigong improved the stress-
coping skills of our volunteers and that this ability was
retained even after exercising was discontinued. This
possibility requires further study.
Previous studies have shown that in vitro production of
IFNγ , IL12 and TNFα  is suppressed by cortisol and that
these cytokines are negatively correlated with plasma
cortisol levels [18]. Administration of cortisone acetate
decreases the IFNγ :IL10 ratio by >70% [19]. Improved
coping with stress might therefore be expected to lower
cortisol and favour type 1 over type 2 cytokine produc-
tion. Our subjects had significantly increased IFNγ  and
reduced IL10-SC in PHA-stimulated cultures after prac-
ticing Qigong for as little as 3 weeks, with even greater in-
creases at 14 weeks. This effect was still seen at 14 weeks
in subjects who stopped exercising at 10 weeks.
However, polarization towards type 1 responses was not
found with all in vitro stimuli. Increases in IFNγ  produc-
tion after Qigong training were less apparent when Con
A or solid-phase anti-CD3 were used. IL10 production
was increased rather than decreased at 7 weeks in un-
stimulated cultures and there was only a trend towards
reduced LPS or SAC-induced IL10 at 14 weeks. Further-
more there were no noticeable effects of Qigong on IL12,
the key inducer of IFNγ  and type 1 cytokines [20], nor on
IL4, the central player in type 2 responses [21].
Unstimulated and stimulated IL6-SC were significantly
increased at 7 weeks, suggesting that a transient inflam-
matory event may have occurred at this time. Cortisol
levels had risen from the reduced levels seen at 3 weeks
and were to fall again at 14 weeks, which might indicate
an increase in stress level of unknown causation at this
time. However, DeRijk et al [22] found that physiological
increased levels of cortisol induced by strenuous exercise
had no effect on LPS-induced IL6, and pharmacological-
ly increased levels were suppressive.
Figure 4
Increased numbers of PHA-induced IFNγ -SC/106 PBM at 3 –
14 weeks of Qigong practice and of Con A-induced IFNγ -SC/
106 PBM at 3 weeks compared with pretraining (A).
Increased numbers of unstimulated IL10-SC/106 PBM at 7
weeks and decreased numbers of PHA-stimulated IL10-SC/
106 PBM at 14 weeks (B). The ratio of PHA-induced IFNγ  :
IL10 increased with duration of Qigong practice (C). (1)p <
0.01, (2) p < 0.05, (3) p < 0.001 compared with P, paired t-
test.
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TNFα -SC increased over baseline in unstimulated cul-
tures at 3 and 7 weeks and fell back to normal at 14 weeks
in subjects who stopped performing exercises at 10
weeks. There was a similar but not significant trend in
PHA-stimulated cultures, whereas in cultures stimulated
with monocyte activators TNFα  levels were suppressed
at 14 weeks even in subjects who stopped exercising at 10
weeks. Unlike IL6, TNFα  is sensitive to suppression by
physiologically-induced increases in cortisol [22] but our
results suggest that if the changes in TNFα  seen in this
study were due to fluctuating cortisol levels then TNFα
induction by T-cell activators and in vivo stimuli may be
affected by cortisol in a different way to that induced by
monocyte activators.
Conclusions
A balance between type 1 and type 2 cytokines is required
for maintenance of health, a preponderance of the
former being associated with certain organ-specific au-
toimmune diseases and of the latter with allergy, system-
ic autoimmunity and suppressed responses to viruses
and cancer [23]. Preliminary evidence from a small, non-
randomized, uncontrolled study has been provided here
that Guolin Qigong might alter cytokine production in
healthy subjects in the direction of type 1 responses.
There is no evidence at present to indicate whether this
would be beneficial, leading to stronger protection
against, for example, cancer and asthma; harmful, lead-
ing to later complications such as autoimmune disease;
or without effect, due to the relatively minor changes in-
duced. Further studies of the effects of Qigong, and of the
various components of Qigong, on clinical, immunologi-
cal and physiological parameters in various disease situ-
ations are, however, clearly merited.
Competing interests
None declared
Acknowledgements
This study was initiated by Dr Vivian Wong, Hospital Chief Executive, 
Queen Mary Hospital, and was supported by the Li Ka Shing Foundation, 
Hong Kong. I am grateful to Dr Janette Kwok for translating and summariz-
ing papers in Chinese, Ms Jacqueline Yuen, who organized and performed 
blood collection from volunteers, Dr Daniel Fong, who helped with statis-
tical analyses, and Drs Jonathan Sham and Peter Lee for useful discussions.
References
1. Chien CH, Tsuei JJ, Lee SC, Huang YC, Wei YH: Effect of emitted
bioenergy on biochemical functions of cells. Am J Chin Med
1991, 19:285-292
2. Sander KM, Hu B: Medical applications of qigong and emitted
qi on humans, animals, cell cultures and plants: review of se-
lected scientific studies. Am J Acupunct 1991, 19:367-377
3. Sander KM: Medical aspects of qigong. Alternative Therapies 1996,
2:40-46
4. Wang C, Xu D, Qian Y: Medical and healthcare qigong. J Trad
Chin Med 1991, 11:296-301
5. Reuther I, Aldridge D: Qigong Yangsheng as a complementary
therapy in the management of asthma. J Altern Complement Med
1998, 4:173-183
Figure 5
IFNγ  production (A), IL10 production (B) and IFNγ :IL10 ratio
(C) at 14 weeks after training in subjects who continued (C)
Qigong practice beyond 14 weeks and those who stopped
(S) at 10 weeks.
A   IFNγ
0
5000
10000 PHA        anti-CD3        Con A
C    S             C    S             C     S
C
K
-
S
C
/
1
0
6
 
P
B
M
 
B   IL10 
0
5000
10000 unstim       PHA       LPS         SAC
 C   S        C   S         C   S        C   S
C
K
-
S
C
/
1
0
6
 
P
B
M
 
C   IFNγ : IL10 (PHA)
0.0
0.4
0.8
1.2
  C                        S
R
A
T
I
O
 BMC Complementary and Alternative Medicine 2001, 1:8 http://www.biomedcentral.com/1472-6882/1/8
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com
6. Kuang A, Wang C, Xu D, Qian Y: Research on "anti-aging" effect
of qigong. J Trad Chin Med 1991, 11:224-227
7. Ryu H, Mo HY, Mo GD, Choi BM, Jun CD, Seo CM, Kim HM, Chung
HT: Delayed cutaneous hypersensitivity reactions in Qigong
(chun do sun bup) trainees by multitest cell mediated immu-
nity. Am J Chin Med 1995, 23:139-144
8. Yao BS: A preliminary study on the changes of T-cell subsets
in patients with aplastic anaemia treated with qigong. Chung
His I Chieh Ho Tsa Chih 1989, 9:341-342
9. Ryu H, Jun CD, Lee BS, Choi BM, Kim HM, Chung HT: Effect of
qigong training on proportions of T-lymphocyte subsets in
human peripheral blood. Am J Chin Med 1995, 23:27-36
10. Higuchi Y, Kotani Y, Hibuchi H, Minegishi Y, Itami J, Uh T, Manda Y:
Endocrine and immune changes during Guolin New Qigong.
J Intl Soc Life Info Science, 1997, 15:138
11. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL:
Two types of murine helper T cell clones. I. Definition ac-
cording to profiles of lymphokine activities and secreted pro-
teins. J Immunol 1986, 136:2348-2357
12. Romagnani S: Lymphokine production by human T-cells in dis-
ease states. Ann Rev Immunol 1994, 12:227-257
13. Czerkinsky C, Nilsson LA, Nygren H, Ouchterlony O, Tarkowsky A:
A solid-phase enzyme-linked immunospot (ELISPOT) assay
for enumeration of specific antibody-secreting cells. J Immunol
Methods 1983, 65:109-121
14. Sedgwick JD, Holt PG: A solid-phase immunoenzymatic tech-
nique for the enumeration of specific antibody-secreting
cells. J Immunol Methods 1983, 65:301-309
15. Jones BM, Kwok CCH, Kung AWC: Effect of radioactive iodine
therapy on cytokine production in Graves' disease. Transient
increases in interleukin-4, IL6, IL10 and tumour necrosis fac-
tor-alpha, with longer-term increases in interferon-gamma
production. J Clin Endocrinol Metabol 1999, 84:4106-4110
16. Jones BM, Liu TF, Wong RWS: Reduced in vitro production of in-
terferon-gamma, interleukin-4 and interleukin-12 and in-
creased production of interleukin-6, interleukin-10 and
tumour necrosis factor-alpha in systemic lupus erythemato-
sus. Weak correlations of cytokine production with disease
activity. Autoimmunity 2000, 31:117-124
17. Jones BM, Kwok JSY, Kung AWC: Changes in cytokine produc-
tion during pregnancy in patients with Graves' disease. Thy-
roid 2000, 10:701-707
18. Petrovsky N, McNair P, Harrison LC: Diurnal rhythms of pro-in-
flammatory cytokines: regulation by plasma cortisol and
therapeutic implications. Cytokine 1998, 10:307-312
19. Petrovsky N, Harrison LC: Diurnal rhythmicity of human cy-
tokine production: a dynamic disequilibrium in T-helper
type 1/T-helper type 2 balance? J Immunol 1997, 158:5163-5168
20. Trinchieri G: Interleukin-12: a proinflammatory cytokine with
immunoregulatory functions that bridge innate resistance
and antigen-specific adaptive immunity. Ann Rev Immunol 1995,
13:251-276
21. Seder RA, Paul WE: Acquisition of lymphokine-producing phe-
notype by CD4+ cells. Ann Rev Immunol 1994, 12:635-673
22. DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Pa-
ciotti G, Gold PW, Sternberg EM: Exercise and Circadian
rhythm-induced variation in plasma cortisol regulate inter-
leukin-1β  (IL-1β ), IL-6, and tumor necrosis factor-ex (TNFα )
production in humans: high sensitivity of TNFα  and resist-
ance of IL-6. J Clin Endocrinol Metabol 1997, 82:2182-2191
23. Romagnani S: The Th1/Th2 paradigm.  Immunol Today 1997,
18:263-266